Business Name: |
Kim Seungtai MD |
Contact Person: |
Seungtai Kim |
Address: |
630 1st Avenue, New York City, New York 10016 |
Phone Number: |
(212) 252-0064 |
Annual Revenue (USD): |
$500.000 to $999.999 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Doctors |
SIC Code: |
8011 |
NAICS Code: |
6211110 |
Share This Business: |
|
Related Businesses: |
Andrew M Milano - New York City, NY 10016 Aubrey C Galloway Surgeon - New York City, NY 10016 Banta Erin M MD - New York City, NY 10016 Allen Sybil MD - New York City, NY 10016 Alonso Carmen M MD - New York City, NY 10016 Barkan Liana H MD - New York City, NY 10016 Amorosi Edward L MD - New York City, NY 10016 Auslender Marcelo J MD - New York City, NY 10016 Aguirre Ameth MD - New York City, NY 10016 Allergy Asthma Care Mnhttn - New York City, NY 10016 Baharestani Samuel MD - New York City, NY 10016 Akowuah Kwame S MD - New York City, NY 10016 Ballas Marc S MD - New York City, NY 10016 Archibald Luke J MD - New York City, NY 10016 Anbarasan Deepti MD - New York City, NY 10016 6C Surgical Assoc - New York City, NY 10016 Allergist on Call - New York City, NY 10016 Advanced Eyecare - New York City, NY 10016 Bansal Amit K DO - New York City, NY 10016 Anthony Dibiase - New York City, NY 10016 |
The company Kim Seungtai MD provides B2C services in the form of Doctors from its single location in New York.
1 to 4 employees work for Kim Seungtai MD, and the business now earns $500.000 to $999.999 per annum.
Kim Seungtai MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Kim Seungtai MD, please call Seungtai Kim with the phone number (212) 252-0064 or visit its single location at 630 1st Avenue in New York City, New York 10016.
The location of the single location can also be found using the coordinates 40.745234,-73.972371.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.